Black Diamond Therapeutics Company
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Founded Date:
2017-01-01
Funding Status:
IPO
Total Funding:
197100000.0
Employee Number:
11-50
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Date:
2019-12-05
Investors Number:
16.0
Last Funding Type:
Series C
Estimated Revenue:
$10M to $50M
Industry:
End-to-End Drug Development